Bank & Trust Company’s Pfizer PFE Stock Holding History

Bank & Trust Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$986K	Hold	40,931	–	–	0.62%	46
2026 Q1	$1.15M	Hold	40,931	–	–	0.77%	37
2025 Q4	$1.02M	Buy	40,931 +353	+0.9%	+$8.9K	0.72%	41
2025 Q3	$1.03M	Hold	40,578	–	–	0.76%	41
2025 Q2	$984K	Sell	40,578 -567	-1%	-$13.2K	0.78%	39
2025 Q1	$1.04M	Buy	41,145 +4,669	+13%	+$122K	0.85%	36
2024 Q4	$968K	Sell	36,476 -476	-1%	-$12.9K	0.81%	34
2024 Q3	$1.07M	Buy	36,952 +227	+0.6%	+$6.62K	0.87%	32
2024 Q2	$1.03M	Buy	+36,725	New	+$1.01M	0.87%	31

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Bank & Trust Company's PFE Position: Q2 2026 in Review

Bank & Trust Company held its Pfizer (PFE) position steady in Q2 2026 at 40,931 shares worth $986K. The position accounts for 0.62% of the portfolio, ranked #46.

Bank & Trust Company first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.15M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bank & Trust Company held 40,931 shares of Pfizer worth $986K as of Q2 2026.
Bank & Trust Company left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.62% of Bank & Trust Company's portfolio in Q2 2026, its #46 holding.
Bank & Trust Company first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Bank & Trust Company's Pfizer position peaked at $1.15M in Q1 2026.
1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.